Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Feb;4(1):65-7.
doi: 10.5489/cuaj.778.

Nephrectomy is necessary in the treatment of metastatic renal cell carcinoma

Tamer Abou Youssif  1 , Simon Tanguay
Affiliations

Nephrectomy is necessary in the treatment of metastatic renal cell carcinoma

Tamer Abou Youssif et al. Can Urol Assoc J. 2010 Feb.
No abstract available

PubMed Disclaimer

References

    1. Flanigan RC, Salmon SE, Blumenstein BA, et al. Nephrectomy followed by interferon alfa-2b compared with interferon alfa-2b alone for metastatic renal-cell cancer. N Engl J Med. 2001;345:1655–9. - PubMed
    1. Mickisch GH, Garin A, van Poppel H, et al. Radical nephrectomy plus interferon alfa-based immunotherapy compared with interferon alfa alone in metastatic renal-cell carcinoma: a randomized trial. Lancet. 2001;358:966–70. - PubMed
    1. Flanigan RC, Mickisch G, Sylvester R, et al. Cytoreductive nephrectomy in patients with metastatic renal cancer: a combined analysis. J Urol. 2004;171:1071–6. - PubMed
    1. Belldegrun A, Shvarts O, Figlin RA. Expanding the indications for surgery and adjuvant interleukin-2-based immunotherapy in patients with advanced renal cell carcinoma. Cancer J Sci Am. 2000;6(Suppl1):S88–92. - PubMed
    1. Zini L, Capitanio U, Perrotte P, et al. Population-based assessment of survival after cytoreductive nephrectomy versus no surgery in patients with metastatic renal cell carcinoma. Urology. 2009;73:342–6. - PubMed

LinkOut - more resources